Increasing clinicians’ suspicion of ATTR amyloidosis using a retrospective algorithm
The results of this study suggest that using this algorithm, despite it not being independently predictive of ATTR, did result in our clinicians having a lower threshold for testing for ATTR. More clinicians ordered appropriate testing, and more positive tests were obtained.
Authors
- John L. Jefferies (ORCID: https://orcid.org/0000-0002-4046-2352)
- Deya Alkhatib (ORCID: https://orcid.org/0000-0003-1418-1124)
- Aranyak Rawal (ORCID: https://orcid.org/0000-0003-3077-8502)
- Isaac Rhea (ORCID: https://orcid.org/0000-0001-8855-1445)
- Jessica Ammon
- John Alexander (ORCID: https://orcid.org/0000-0001-7275-1514)
- Woodson Petit-Frere
- G. Newman
- Oguz Akbiligic
- Brian Borkowski
Institutions
- University of Tennessee Health Science Center (US)
- Yale University (US)
- Methodist Le Bonheur Healthcare (US)
- Wake Forest University (US)
- University of Memphis (US)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1186/s40959-024-00282-6
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00